Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks
NASDAQ:MGRX

Mangoceuticals 10/27/2023 Earnings Report

Mangoceuticals logo
$2.25 +0.29 (+14.80%)
Closing price 04:00 PM Eastern
Extended Trading
$2.26 +0.00 (+0.22%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
ProfileEarnings History

Mangoceuticals EPS Results

Actual EPS
-$24.75
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Mangoceuticals Revenue Results

Actual Revenue
$0.25 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Mangoceuticals Announcement Details

Quarter
Date
10/27/2023
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Mangoceuticals Earnings Headlines

Mangoceuticals, Inc. (NASDAQ:MGRX) Short Interest Update
August 22, 2025  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30290947
Mangoceuticals (NASDAQ:MGRX) Raised to "Hold" at Wall Street Zen
August 18, 2025  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30283185
Why More Investors Are Using Family Trusts to Protect Their Wealth
For many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensuring wealth is passed on according to your wishes. Trusts may also provide shielding from creditors and lawsuits while offering potential tax advantages—especially with estate tax thresholds set to decrease in 2026. If you’re considering whether a family trust is right for you, speaking with a fiduciary financial advisor can help you decide the best path forward. We’ve created a free tool that matches you with vetted advisors in your area—each legally bound to act in your best interest.tc pixel
August 28 at 2:00 AM  |  SmartAsset (Ad)
Mangoceuticals Terminates Agreement with Navy Wharf
August 4, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/mangoceuticals-terminates-agreement-with-navy-wharf?utm_source=marketbeat.com&utm_medium=referral
Mangoceuticals President Tony Isaac Resigns
July 3, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/mangoceuticals-president-tony-isaac-resigns?utm_source=marketbeat.com&utm_medium=referral
Mangoceuticals Strengthens Position with Equity Transactions
June 10, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/mangoceuticals-strengthens-position-with-equity-transactions?utm_source=marketbeat.com&utm_medium=referral
See More Mangoceuticals Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Mangoceuticals? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Mangoceuticals and other key companies, straight to your email.

About Mangoceuticals

Mangoceuticals (NASDAQ:MGRX) develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.

View Mangoceuticals Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles